Precision CellSystems

Executive Summary

Precision CellSystems is a San Diego-based biotechnology company specializing in automated, precision instruments for critical cell-based workflows. Founded in 2015, the company addresses upstream sample preparation variability—including tissue dissociation, cell counting, and fluorescence phenotyping—to ensure data integrity for downstream research and regulated cell therapy manufacturing. Its software-locked platforms provide reproducibility, auditability, and improved cell recovery, targeting advanced genomics and cell therapy applications. As cell therapies transition from lab to clinic, Precision CellSystems is well-positioned to supply essential tools that reduce human error and increase consistency, thereby accelerating development timelines and enhancing manufacturing reliability. The company operates in the rapidly growing cell therapy and regenerative medicine sectors, where demand for standardized, automated solutions is increasing. With a focus on eliminating variance early in the workflow, Precision CellSystems differentiates itself through rigorous quality control and audit-ready outputs. While the company remains private with limited public financial data, its niche focus on upstream automation addresses a critical bottleneck in cell therapy production. If successful, its instruments could become standard in research labs and GMP manufacturing facilities, supporting scale-up from discovery to commercialization.

Upcoming Catalysts (preview)

• H2 2026Launch of next-generation automated cell processing platform75% success
• Q3 2026Strategic partnership with a top-10 cell therapy developer60% success
• 2026Series B funding round or major government grant70% success